CRISPR Therapeutics Cash from Operations (TTM)

CRISPR Therapeutics AG (CRSP)

43.44

+0.30 (+0.68%) USD | NASDAQ | Mar 24, 16:00

43.43 0.00 (0.00%) After-Hours: 18:24

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2022	-495.74M
September 30, 2022	-468.45M
June 30, 2022	-444.56M
March 31, 2022	504.40M
December 31, 2021	538.97M
September 30, 2021	543.80M
June 30, 2021	549.43M
March 31, 2021	-286.85M
December 31, 2020	-238.37M
September 30, 2020	-153.78M
June 30, 2020	55.34M
March 31, 2020	48.24M
December 31, 2019	56.68M

Date	Value
September 30, 2019	24.93M
June 30, 2019	-128.46M
March 31, 2019	-117.29M
December 31, 2018	-96.24M
September 30, 2018	-82.71M
June 30, 2018	-78.61M
March 31, 2018	-69.37M
December 31, 2017	-70.09M
September 30, 2017	-72.22M
June 30, 2017	-68.62M
March 31, 2017	-66.26M
December 31, 2016	-52.86M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-495.74M

Minimum

Dec 2022

549.43M

Maximum

Jun 2021

-16.93M

Average

-80.66M

Median

Cash from Operations (TTM) Benchmarks